OLMICOMBI 40mg / 12.5mg tablets medication leaflet

C09DA08 • olmesartan + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

This combination of olmesartan and hydrochlorothiazide is used for the treatment of hypertension in patients not adequately controlled with a single medication. Olmesartan blocks angiotensin II receptors, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, electrolyte imbalances, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.